Rationale: According to the immortal DNA strand hypothesis, dividing stem cells selectively segregate chromosomes carrying the old template DNA, opposing accumulation of mutations resulting from nonrepaired replication errors and attenuating telomere shortening.
lation of mutations resulting from nonrepaired replication errors and prevents partly telomere shortening. 9 -11 The applicability of this concept to adult stem cells has been challenged 12 and arguments against this mechanism of stem cell division have been raised. 13 If the immortal DNA strand theory is correct, the number of mother stem cells is genetically determined early in life, and this category of "true" stem cells may decrease dramatically with age as a result of environmental factors, oxidative stress, and disease processes, which characterize the progression of life in humans. However, CSCs retaining the old DNA would represent the most powerful stem cell to repopulate the damaged heart. Importantly, the documentation that CSCs divide by asymmetrical chromatid segregation (ACS) would provide strong evidence in favor of the notion that the human heart is a selfrenewing organ regulated by a compartment of resident CSCs.
Methods
Human myocardial samples (Nϭ29) were used to isolate and expand CSCs that divided by ACS and symmetrical chromatid segregation (SCS). In vitro and in vivo functional assays were performed to assess the growth properties of these cells. An expanded Methods section is provided in the online-only Data Supplement.
Results

Pattern of Division of Human CSCs
Clonal assay of human CSCs (hCSCs) is required to discriminate SCS and ACS during mitosis (Online Figure IA and IB).
The ancient "grandparent" DNA cannot be targeted by exogenously delivered thymidine analogs and the coexistence of old and newly synthesized labeled "parent" DNA is lost in the second generation (Online Figure IC) , 10,11,14 -17 making it difficult to follow in vivo the destiny of hCSCs carrying the immortal DNA. Thus, division of hCSCs by SCS and ACS was documented by clonal assay of bromodeoxyuridine (BrdU) tagged parent hCSCs. This protocol underscores at the stem cell level, ie, clonogenicity, whether clonal cells formed by division of BrdU-positive parent hCSCs show only 1 BrdU-labeled cell (newly synthesized strand of parent DNA), whereas all other hCSCs in the clone are BrdU-negative, being the descendants of the parent MeanϮSD. The sequence of the phases of the cell cycle, ie, G2, S, and G1, reflects the order in which cells enter mitosis after the BrdU pulse. Cells in G2 are the first to reach mitosis; these cells, however, are BrdU-negative. Subsequently, cells that are in S phase will divide and the mitotic figures will be BrdU-positive, deflecting upward the labeled mitosis curve. Finally, cells in G1 at the time of the BrdU pulse will reach mitosis; they will be BrdU negative and mitotic figures will be no longer labeled by the thymidine analog. B, Lineage-negative c-kit-positive hCSCs (green) are BrdU-positive (white) before plating for clonal analysis. C, Individual lineagenegative c-kit-positive hCSCs (green) were plated at limiting dilution (left panel), or seeded in single wells of Terasaki plates (right panel). BrdU, white. D, Clonal efficiency in each sample is shown together with the meanϮSD.
Figure 2. Clonal growth of human cardiac stem cell (hCSC). A,
Clones derived from hCSCs carrying the old (red) and new (blue) DNA in each patient. MeanϮSD is shown. B, Linear relationship between age and number of clones formed by hCSCs carrying the old (red) and new (blue) DNA. C, Two clones having each 1 BrdU-positive hCSC (arrowheads). The BrdU-positive hCSC is shown at higher magnification in the inset (lower left panel; arrowheads); BrdU-positive and BrdU-negative hCSCs are negative for p16 INK4a . hCSCs exposed to doxorubicin were used as positive control for p16 INK4a expression (lower right panel; magenta, arrows). D, Clonal hCSCs derived by asymmetrical and symmetrical chromatid segregation are predominantly undifferentiated and express at very low level epitopes of cardiomyocytes [GATA4, cell retaining the unlabeled DNA. Conversely, clones formed by hCSCs dividing by SCS are expected to contain cells that are all BrdU-positive (Online Figure ID) , although dilution of BrdU occurs with clonal expansion. This analysis was conducted in hCSCs isolated from 29 myocardial samples (Online Table I ).
Lineage-negative-c-kit-positive hCSCs were exposed to BrdU for Ϸ4 cell cycles to label all cells. For clonal assay, Ϸ16,600 hCSCs/specimen were plated and 2725 clones were obtained ( Figure 1) ; 203 clones were characterized by BrdUlabeling of a single hCSC, indicating that 7% of founder hCSCs divided by ACS ( Figure 2A ; Online Figure IIA and IIB). This value decreased linearly with age, whereas the fraction of clones derived from hCSCs dividing by SCS increased ( Figure 2B ). Clonal efficiency and the fraction of hCSCs dividing by ACS were comparable in female and male samples (Online Figure IIC-IIE). Thus, hCSCs consist of 2 cell classes that self-renew by ACS and SCS, respectively.
Single BrdU-Positive hCSC
The BrdU-labeled cell in the clones generated by hCSCs dividing by ACS was analyzed to determine possible alternatives to the immortal DNA strand hypothesis: 13 (a) the BrdU-positive hCSC may have reached replicative senescence and growth arrest, early in the formation of the clone; (b) the nonsenescent BrdU-labeled sister cell may be responsible for the generation of the clone with dilution of BrdU, which became undetectable by immunolabeling; and (c) the BrdU-positive hCSC may reflect a cell blocked in S-phase, due to replication errors and activation of the DNA repair machinery.
Forty clones, each containing 1 BrdU-positive hCSC, were stained for the senescence-associated protein p16 INK4a that prevents reentry of stem cells into the cell cycle. 18 In these clones, BrdU-positive and BrdU-negative cells did not express p16 INK4a (Figure 2C ), excluding that the hCSC that inherited the newly synthesized DNA reached growth arrest. Importantly, by confocal microscopy, a 200-fold difference between the BrdU signal and autofluorescence can be detected. To illustrate this critical issue, spectral analysis of BrdU labeling has been performed to document that BrdU can be distinguished up to 10 divisions of hCSCs (Online Figure IIF To confirm that the BrdU-positive cell present in each clone did not acquire the senescent phenotype, we documented that the BrdU-positive cells were capable of incorporating EdU, another thymidine analog. Additionally, frequent examples of BrdU-positive cells expressing Ki67 were found, providing independent evidence that they continue to proliferate (Online Figure IIH) . Moreover, proteins indicative of DNA repair, p53, and ATM kinase 19 were absent in BrdU-positive cells, which showed a diploid DNA content (Online Figure 
hCSCs and Their Progeny
According to the immortal DNA strand hypothesis, ACS is equivalent to asymmetrical stem cell division, questioning the ability of stem cells to undergo symmetrical division with formation of 2 indistinguishable sibling cells. Theoretically, these cells cannot divide and form 2 daughter stem cells or 2 daughter parenchymal cells. 9 -11,14,20 Thus, we determined whether clones generated by hCSCs dividing by ACS were composed of only 1 true stem cell and a cluster of committed cells (Online Figure IIIA and IIIB). Both cell classes were FACS-sorted and Ͻ1% expressed proteins specific for myocytes, endothelial cells, and smooth muscle cells ( Figure 2D ). These results exclude lineage specification of clonal cells, whether derived from hCSCs dividing by nonrandom or random DNA template segregation. hCSCs were then exposed to a BrdU-pulse followed by a chase-period in which hCSCs traversed 1 cell cycle in the absence of the thymidine analog. BrdU incorporation in anaphase/telophase nuclei was determined together with the uniform or nonuniform partitioning of ␣-adaptin, which identifies symmetrical and asymmetrical hCSC division, respectively. 21 In most cases, both sets of anaphase/telophase chromosomes were BrdU-positive (Online Figure IIIC-IIIE) , and ␣-adaptin showed a bipolar localization (Online Figure  IIIE) , reflecting SCS and symmetrical stem cell division. In a small number of cells, BrdU was restricted to 1 set of chromosomes ( Figure 2E and 2F), but ␣-adaptin was evenly distributed ( Figure 2F ), indicating that ACS was coupled with symmetrical stem cell division.
DNA Partitioning in Dividing hCSCs
However, the apparent inhibition of cell replication of the BrdU-bright hCSC present in clones derived from founder cells dividing by ACS remained unexplained. Thus, chlorodeoxyuridine (CldU)-labeled parent hCSCs were plated for clonal assay. Iododeoxyuridine (IdU) was added for the duration of 1 cell cycle to identify newly synthesized DNA in the first generation of 2 daughter cells formed by CldU-labeled parent hCSCs. IdU was then removed and the localization of CldU and IdU in the second (4 cells), third (8 cells), and fourth (16 cells) generations was evaluated.
hCSCs dividing by SCS gave rise to clones in which all cells were positive for CldU and IdU ( Figure 3A ). An unexpected form of labeling was found in 5% of clones ( Figure 3B-3E ). In clones of 2 cells, 1 cell was positive for IdU and the other for CldU and IdU. In clones of 4 cells, 1 was positive for CldU, 2 were positive for IdU, and 1 was negative for both CldU and IdU. Clones of 8 cells showed 1 cell positive for CldU, 2 positive for IdU, and 5 negative for both CldU and IdU. Clones of 16 cells showed 1 cell positive for CldU, 2 positive for IdU, and 13 negative for both CldU and IdU; larger clones will always have 1 CldU and 2 IdU positive cells, with the remaining hCSCs unlabeled.
hCSCs dividing by ACS treat the newly formed DNA as immortal in subsequent divisions, so that the labeled-DNA is retained only in 1 set of duplicated chromosomes (Online Figure hCSCs dividing by ACS may form clones that, at all times, are composed of 50% cells harboring the old DNA, and 50% cells carrying the new DNA. Expanding clones were exposed to BrdU for 1 cell cycle and a second round of division was allowed in the absence of BrdU; in each clone, Ϸ50% of cells were BrdU-positive and Ϸ50% of cells were BrdU-negative (Online Figure IVF) . Thus, Ϸ5% of hCSCs divide by ACS, possessing a molecular signature that regulates the spatial partitioning of old and newly synthesized DNA during mitosis.
ACS
The mitotic spindle uses dynamic microtubules and mitotic motors to drive the movements that underlie "search and capture" of chromosomes, and their alignment and segregation. 22 In an attempt to understand the molecular basis of the biased segregation of chromatids in hCSCs, we studied the left-right dynein motor protein (LRD), 23 that regulates the modality of cell division and embryonic left-right body axis asymmetry. 24 LRD mRNA was highly expressed in hCSCs and to a lesser extent in human myocardium ( Figure 3F ;
BrdU-labeled hCSCs were transduced with a plasmid or lentivirus containing siRNA for LRD and EGFP, FACSsorted for EGFP, and plated for clonal assay. Control hCSCs, transduced with scrambled siRNA, expressed normal levels of LRD. Nearly 5% of clones generated by control hCSCs showed a single BrdU bright cell, reflecting the expected fraction of hCSCs dividing by ACS. Conversely, downregulation of LRD in hCSCs led to clones formed almost exclusively by SCS ( Figure 3F ), suggesting that LRD is implicated in ASC during mitosis.
Growth of hCSCs
The growth of hCSC classes was determined by measuring the size of the clones and the characteristics of their progeny; at 7 days, the number of cells in 214 clones derived from hCSCs dividing by ACS was 1.8-fold higher than in 188 clones of hCSCs dividing by SCS ( Figure 4A ). This difference reached 4.1-fold at 12 days and was dictated by a 17% shorter population doubling time of hCSCs replicating by ACS. Although clonal cells with old DNA divided more frequently, only 11 p16 INK4a -positive and 2 apoptotic hCSCs were detected in 214 clones. Conversely, 91 p16 INK4a -positive and 38 apoptotic hCSCs were found in the 188 clones derived from hCSCs harboring the new DNA ( Figure 4B ).
In hearts 1 to 16 years old, telomere length varied from 6.0 to 12 kbp in both hCSC classes; however, in hearts 46 to 83 years old, telomere length varied from 5.0 to 12 kbp and from 2.0 to 11 kbp in hCSCs carrying the old and new DNA, respectively. Telomere length decreased linearly with age only in hCSCs dividing by SCS ( Figure 4C ); its preservation in hCSCs harboring the old DNA may reflect the protection of telomeric DNA at the 3Ј chromosomal end during S-phase. 11, 13 Telomerase activity was comparable in these stem cell classes ( Figure 4D ). Epigenetic marks in the longer telomeres of hCSCs with old DNA may account for the more effective maintenance of chromosomal ends in this stem cell pool. 13 This mechanism is operative in stem cells with high selfrenewing potential, 19, 25, 26 a property found here in hCSCs harboring the old DNA. Thus, hCSCs dividing by ACS constitute a stem cell pool with high degree of growth reserve and self-renewing ability, critical variables for effective cardiac homeostasis and repair.
Isolation of hCSC Classes
To document the clinical importance of hCSCs with old and new DNA, we developed a protocol that allowed the identification and collection of both subsets of living hCSCs. This strategy takes advantage of the interaction between the BrdU integrated in the DNA of replicating hCSCs and the fluorescence intensity of DNA dyes. 27, 28 The nucleic acid dye TO-PRO-3 intercalates randomly in double-stranded DNA and when located near BrdU-adenosine pairs, its inherent level of fluorescence is dramatically enhanced. 28 This does not occur with nonintercalating dyes, eg, propidium iodide (PI); the fluorescence quantum yield of PI is independent of neighboring nucleotides. 27 If DNA is labeled by both PI and TO-PRO-3, however, fluorescence resonance energy transfer occurs from PI to TO-PRO-3 with fluorescence excitation at 530 nm. 29, 30 This interaction decreases the fluorescence intensity of PI and increases the fluorescence intensity of TO-PRO-3 (Online Figure VI) . hCSCs were exposed to BrdU for Ϸ5 to 6 population doublings to achieve nearly 100% labeling. Subsequently, BrdU-positive hCSCs were stained with both PI and TO-PRO-3. The presence of BrdU led to a decrease in amplitude of the PI spectrum and to an increase of TO-PRO-3 signal (Online Figure  VII) . The possibility to label live hCSCs with PI and TO-PRO-3 is illustrated in Online Figure VIIIA . A chase period of 36 hours was then introduced to allow hCSCs dividing by ACS to transfer the newly synthesized BrdU-labeled DNA to 1 of the 2 daughter cells. The presence of BrdU further enhanced the fluorescence resonance energy transfer reaction so that living BrdU-positive (new DNA) and BrdU-negative (old DNA) hCSCs can be FACS sorted (Online Figure VIIIB) . These 2 hCSC subsets were cultured and population doubling time (PDT) was determined. Consistent with previous results ( Figure 4A ), hCSCs dividing by ACS had shorter PDT, Ϫ18%, and a higher growth rate, ϩ22% (Online Figure VIIIC) .
The use of PI and TO-PRO-3 makes the implementation of this protocol in patients uncertain. Autologous hCSCs are currently being used in a phase 1 clinical trial, 31 and stem cells dividing by ACS may be used in patients in the future. We took advantage of the photosensitizing effects of BrdU 29 to eliminate by apoptosis BrdU-positive hCSCs and collect only hCSCs harboring the old DNA (Online Figure IX) . PDT, telomere length, and the cell karyotype were determined in this category of hCSCs to assess the effects of photosensitization on these critical parameters of stem cell growth and chromosomal integrity; the values of PDT ( Figure 5A ) and telomere length ( Figure 5B ) were comparable with those obtained previously (see Figure 4A and 4C) and the cell karyotype was unaltered ( Figure 5C ). However, we cannot exclude that this protocol may have failed to identify less apparent chromosomal abnormalities.
Myocardial Regeneration
We used FACS-fluorescence resonance energy transfer or UV-light to collect live clonal hCSCs with old and new DNA; hCSCs were infected with EGFP-lentivirus for subsequent tracking. Cardiac repair induced by these hCSC classes was determined in immunosuppressed rats 15 days after infarction and cell delivery. 6, 21 Untreated animals were injected with PBS, because we have previously shown that human c-kit-negative cells or PBS do not promote myocardial regeneration. 6 Additionally, the current objective was to compare the extent of cardiac repair mediated by hCSCs dividing by ACS or SCS.
In all cases, infarct size comprised Ϸ50% of myocytes of the left ventricle and septum. Clonal hCSCs with old DNA led to an almost complete reconstitution of the infarct ( Figure  6A ; Online Figure XA-XC) , a reparative response never seen previously. 6, [32] [33] [34] [35] [36] With this protocol, infarct wall thickness was greater and chamber diameter was smaller, resulting in a remarkable recovery of wall thickness-to-chamber radius ratio ( Figure 6B ). hCSCs with old DNA formed 60 mm 3 of human myocardium, which was 2.4-fold larger than that with hCSCs carrying the new DNA, 25 mm 3 . These degrees of cardiac repair restored 82% and 38% of the infarct, respectively. The 2.2-fold higher regeneration obtained with hCSCs carrying old DNA was mediated by a parallel increase in number of new myocytes ( Figure 6C ). These myocytes showed sarcomere striation and connexin 43 and N-cadherin ( Figure 6D) .
The aggregate length of human arterioles and capillaries increased dramatically in the reconstituted myocardium following the delivery of hCSCs carrying the old DNA ( Figure 6E and 6F; Online Figure XD) . The human origin of the regenerated structures was confirmed by detection of human DNA sequences with an Alu probe and human X-chromosome ( Figure 7A ). Both hCSC subsets ameliorated ventricular hemodynamics ( Figure 7B) ; however, the recovery of systolic pressure, developed pressure, positive and negative dP/dt was greater with hCSCs carrying the old DNA. This improvement in cardiac anatomy and function led to a marked attenuation in diastolic wall stress.
To test whether the inhomogeneity of the infarcted myocardium favored the incidence of arrhythmia, hearts were exposed ex vivo to electric stimulation inducing tachycardia and fibrillation. 37 Arrhythmia was not detected in sham-operated hearts, but 92% of infarcted nontreated hearts showed episodes of arrhythmia. This value decreased to 43% with hCSCs harboring new DNA, but none of the 12 hearts injected with hCSCs dividing by ACS showed tachycardia or fibrillation ( Figure 7C ). Collectively, these results emphasize the role that hCSCs with old DNA have in conditioning an effective restoration of the mechanical and electric properties of the infarcted heart, representing a superior form of cell therapy for ischemic myocardial injury.
Serial Transplantation of hCSCs Dividing by ACS
The identification of a novel class of hCSCs carrying the old DNA imposed on us the need to test its self-renewal property in vivo by serial transplantation assay. 38 -40 A protocol identical to that used above was used; 15 days after infarction and cell implantation, the left ventricle was enzymatically dissociated and cells were sorted for c-kit and EGFP ( Figure 8A) ; Ϸ10,000 hCSCs were recovered from each heart. These cells were delivered immediately to the infarcted region of subsequent recipients. Fifteen days after treatment, human myocytes and coronary vessels were identified, replacing large areas of the infarcted myocardium ( Figure 8B) . Again, undifferentiated hCSCs were detected ( Figure 8C) , providing further evidence in support of the self-renewal and long-term proliferation in vivo of hCSCs carrying the old DNA. Importantly, human transcripts for cardiomyocyte, smooth muscle cells, and endothelial cell genes were demonstrated by q-RT-PCR in the infarcted heart 7 to 10 days after serial transplantation ( Figure  8D ; Online Figure XI ).
Discussion
Our results provide evidence that the human heart possesses a pool of hCSCs that, during division, undergo ACS, generating 2 daughter stem cells, which retain the old and new DNA, respectively. This pattern of stem cell replication is conserved in subsequent divisions, preserving exponential cell growth and attenuating, partly, telomere attrition. Selective partitioning of chromatids in cycling hCSCs may be regulated by the LRD protein, which is required for the biased segregation of the leading and lagging strands of the DNA in daughter cells. 23 These observations support only to some extent the immortal DNA strand hypothesis. 9 According to this theory, cells carrying the old DNA function as stem cells, whereas cells containing the newly synthesized DNA undergo lineage specification; ACS was considered equivalent to asymmetrical stem cell division. 9 However, this does not appear to be the case; hCSCs divide symmetrically and asymmetrically in vitro and in vivo generating daughter cells with identical or divergent fate. 6, 21 These modalities of hCSC growth were determined here and previously based on the localization of the endocytic proteins numb and ␣-adaptin, and the function of the Notch receptor. 5, 6, 21, 41 The growth behavior of hCSCs strongly suggests that nonrandom chromatid segregation does not determine the fate of daughter cells, as claimed by in vivo studies of neural, skeletal muscle, and intestinal stem cells. 10, 15, 16, 20 ACS and SCS of replicating hCSCs were documented by clonal assay in vitro, as the recognition of the destiny of the daughter cells. In vivo strategies can define whether asymmetrical or symmetrical stem cell division occurs, 25 but this critical aspect of stem cell growth cannot be interpreted in the context of nonrandom or random chromatid segregation. 12, 42 Chromosome orientation-fluorescence in situ hybridization (CO-FISH) of metaphase spreads, or tissue sections allows the discrimination of the pattern of DNA segregation at the single chromatid level, 14, 20 but the presence or absence of markers of stemness and commitment remains to be defined. This limitation applies to the multiisotope imaging mass spectrometry method 42 and to the partial ACS shown in mouse cardiac progenitor cells. 43 Additionally, the in vivo behavior and therapeutic efficacy of these progenitor cells have never been documented. Importantly, our observations are consistent with the view that all chromosomes are involved in the process, excluding that sister chromatid exchange occurs 20 or that only a unique subset of chromosomes divides by ACS. In vivo studies attempting to document the modality of chromosome segregation by consecutive delivery of distinct thymidine analogs are difficult to interpret because of the complexity to precisely define the length of the cell cycle in the dividing stem cells. This information is critical for an accurate analysis of the distribution of DNA labeling and the fate of the target cell.
The probability that a random segregation of chromatids can yield an asymmetrical distribution of labeled nucleotide can be calculated. Because each chromatid has a 50% likelihood of being allocated to 1 of the 2 daughter cells, and the number of chromatid pairs in a mitotic human cell equals 46, Pϭ0.5 46 ϭ0.000000000000014. This implies that 1 out of 70,000,000,000,000 clones would have by chance a single BrdU-positive cell. If we would be able to analyze 1 clone per second, it would take more than 2 million years to find one. Thus, random events cannot explain the magnitude of the phenomenon reported here.
hCSCs and cardiospheres containing a small pool of hCSCs in the core have recently been introduced clinically in the treatment of chronic 31 and subacute 44 postinfarction myopathy. Both protocols require the in vitro expansion of resident stem cells 31 and cardiac-derived cells, 44 emphasizing the relevance of the present study. hCSCs carrying the old DNA have long telomeres and generate a large pool of nonsenescent cells. This high self-replicating potential exceeds significantly the growth of hCSCs that possess only the newly synthesized DNA, making the former class of stem cells a more desirable progenitor for myocardial regeneration. hCSCs with old DNA lead to a restoration of the infarcted myocardium, which is structurally and functionally superior to that induced by hCSCs with new DNA. Replacement of the entire infarcted region of the wall with newly formed cardiomyocytes and coronary vessels has never been seen before with CSCs and non-CSCs. 6, [32] [33] [34] [35] [36] 45 At most, a 40% reduction of infarct size has been found following delivery of "nonclonal" hCSCs pretreated with ephrin A1 that potentiates significantly the migration of the injected cells within the infarcted myocardium. 46 This value is comparable to that obtained here with "clonal" hCSCs carrying the new DNA and significantly lower than that reached with "clonal" hCSCs carrying the old DNA. These differences in tissue reconstitution reflected similar differences in the number of regenerated human cardiomyocytes, arterioles, and capillaries. The impressive recovery in ventricular hemodynamics and anatomy mediated by clonal hCSCs carrying the "mother" DNA underscores the importance of this stem cell category for the management of ischemic and nonischemic heart failure.
Whether the small number of hCSCs carrying the old DNA is dictated by the multiple unpredictable variables experienced by the human heart during the course of life is difficult to establish. The number of hCSCs with old DNA is negatively influenced by age, which is the major independent risk factor of heart failure in the Western world 47 ; however, these results leave unanswered the question whether stem cell division and lineage specification are causally related to the cardiac disease and its duration. The pathophysiology of the decompensated cardiomyopathy remains unknown, but defects in stem cells may condition the accumulation of hypertrophied, poorly contracting myocytes that define the failing cardiac phenotype. 48 The role of random and nonrandom DNA template segregation and cell fate will have to be determined in a large patient cohort to characterize the contribution of stem cell growth and differentiation to the manifestations of the old failing heart.
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